Endothelial Dll4-Notch signaling in tumor microenvironment: is there any hidden therapeutic opportunity?

Amit Kumar1, Sejal Desai1, Badri N Pandey1

  • 1Radiation Signaling and Cancer Biology Section, Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai-400 085, India.

Insights

Tumor microenvironment interactions are key in cancer. Delta-like ligand 4 (Dll4) and Notch signaling regulate tumor growth, but further research is needed to target this pathway for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Tumor microenvironment communication between endothelial and cancer cells influences cancer progression and treatment.
  • Endothelial delta-like ligand 4 (Dll4) signaling, triggered by vascular endothelial growth factor (VEGF), is crucial for angiogenesis and tumor growth via the Notch pathway.
  • The role of Dll4-Notch signaling in diverse cancer types is under investigation.

Purpose of the Study:

  • To elucidate the intricate mechanisms of Dll4-Notch signaling within the tumor microenvironment.
  • To identify key molecular players and pathways involved in endothelial-cancer cell cross-talk.
  • To explore the therapeutic potential of targeting the Dll4-Notch pathway in cancer treatment.

Main Methods:

  • Investigating the molecular interactions between endothelial cells and cancer cells.
  • Utilizing in vitro and in vivo models to study Dll4-Notch signaling pathways.
  • Analyzing gene and protein expression related to angiogenesis and tumor growth.

Main Results:

  • Demonstrated a significant role for Dll4-Notch signaling in mediating tumor angiogenesis and growth.
  • Identified specific cross-talk mechanisms between endothelial and cancer cells mediated by Dll4.
  • Observed modulation of tumor progression in response to interventions targeting the Dll4-Notch pathway.

Conclusions:

  • Dll4-Notch signaling is a critical component of the tumor microenvironment, impacting cancer progression.
  • Understanding these signaling pathways is essential for developing novel cancer therapeutics.
  • Targeting Dll4-Notch signaling presents a promising strategy for future cancer therapy development.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.9K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K